NCT07147348
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07147348
Title A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Cancer Research SA NOT_YET_RECRUITING Adelaide 5000 Australia Details
Monash Medical Centre NOT_YET_RECRUITING Clayton 3168 Australia Details
Peter MacCallum Cancer Centre NOT_YET_RECRUITING Melbourne 3000 Australia Details
The Alfred Hospital RECRUITING Melbourne 3004 Australia Details
One Clinical Research NOT_YET_RECRUITING Nedlands 6009 Australia Details
Scientia Clinical Research Limited RECRUITING Randwick 2031 Australia Details
Beijing Cancer Hospital RECRUITING Beijing 100142 China Details
Anhui Provincial Hospital RECRUITING Hefei 230061 China Details
First Affiliated Hospital of Xinxiang Medical University RECRUITING Henan 453003 China Details
Hunan Province Cancer Hospital NOT_YET_RECRUITING Hunan 410006 China Details
Shandong University-Jinan Central Hospital NOT_YET_RECRUITING Shandong 250013 China Details
Linyi Tumor Hospital RECRUITING Shandong 276001 China Details
Shanghai East Hospital RECRUITING Shanghai 200120 China Details
Shanghai GoBroad Cancer Hospital RECRUITING Shanghai 200131 China Details
Sichuan Cancer Hospital RECRUITING Sichuan 610041 China Details
Zhejiang Cancer Hospital RECRUITING Zhejiang 310022 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field